Joined-Up EU Approach Is Key To Continuing COVID-19 Fight
Multi-Stakeholder Approach Must Be Maintained, Medicines For Europe Insists
Executive Summary
At a Medicines for Europe webinar on learning lessons from the COVID-19 pandemic, a clear consensus emerged that a continued co-ordination between industry, regulators and the European Commission was key to both effectively address the current crisis and ensure a greater level of preparedness for similar challenges in future.
You may also be interested in...
Europe Must Look Beyond Price To Secure Supply Chain
European procurement models that focus solely on the lowest-cost generics are jeopardizing efforts to strengthen the supply chain and secure investments in local manufacturing, says Christoph Stoller, president of Medicines for Europe.
Procurement Must Look Beyond Price To Ensure Supply Chain Security
A globally co-ordinated approach to sourcing that rewards non-pricing criteria is imperative to bolster the security of the off-patent industry’s supply chain in the wake of the coronavirus pandemic, James Burt tells Generics Bulletin in the second part of our exclusive interview.
EU Rips Up Competition Rulebook To Allow Collaboration On Coronavirus
A temporary framework has been adopted by the European Commission that will allow companies and associations to co-ordinate efforts to tackle the coronavirus pandemic without raising competition concerns. The move has been welcomed by the European off-patent industry.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: